Dr Ekta Vala ChandaranaMedical Oncologist

Targeted Therapy for Breast Cancer: The Latest Advances

By Dr Ekta Vala Chandarana, Senior Consultant Medical Oncologist
Updated September 2025

Close-up of a breast cancer patient with a pink ribbon receiving support, symbolizing targeted therapy treatment

Breast cancer treatment has changed a lot in the last few decades. Earlier, we had only surgery, chemotherapy and radiation. Today, treatment is more exact and planned for each person. One of the most hopeful options is targeted therapy for breast cancer - medicines that attack the exact molecules or signals that help cancer cells grow, divide and spread.

Normal chemotherapy affects both healthy cells and cancer cells. Targeted therapy goes mainly after the cancer cells. So it often works better and causes fewer side effects. It is truly changing how we treat breast cancer.

Targeted therapy: treatment planned for your cancer

Targeted therapy is chosen based on the special features of your own tumour. Every breast cancer is different inside its cells. We now know that if we aim at these differences, treatment can work much better.

Let me explain how it works:

  • Finding the target: we test the tumour's genes, proteins and signals.
  • Choosing the medicine: the medicines are made to block those targets that drive the cancer.
  • Killing cancer cells: when the signals that cancer cells need are blocked, the tumour grows slower or stops growing.

Because it is planned so closely for each person, targeted therapy is often called "precision medicine."

How targeted therapy differs from older treatments

FeatureTargeted TherapyChemotherapyRadiation
MechanismTargets specific molecules or pathways in cancer cellsKills rapidly dividing cells (cancerous and healthy)Damages DNA in cancer cells to stop growth
PrecisionHighly specific to cancer typeLess specificLocalized to tumor area
Side EffectsOften fewer and milderMore severe, systemicLocalized side effects
SuitabilityBased on molecular testingOften used as standard careUsed for localized disease

Because it is so exact, targeted therapy often works better and helps you feel better day to day, compared to older treatments alone.

Types of targeted therapy for breast cancer

There is no one targeted medicine for everyone. I choose the type based on the molecular subtype (the inner type) of your breast cancer. These are the most common types:

1. HER2-targeted therapies

About 20% of breast cancers make too much of a protein called HER2. This protein helps cancer cells grow. Targeted medicines can block it.

Examples:

  • Trastuzumab (Herceptin): one of the first targeted medicines. It sticks to HER2 and blocks the growth signals.
  • Pertuzumab (Perjeta): works together with trastuzumab, so HER2 is blocked in two ways.
  • Ado-trastuzumab emtansine (Kadcyla): a targeted medicine joined with chemo, so the chemo goes straight into cancer cells.

Used for: HER2-positive breast cancers

2. CDK4/6 inhibitors

These medicines block proteins called cyclin-dependent kinases (CDK4 and CDK6), which help cancer cells divide.

Common CDK4/6 inhibitors:

  • Palbociclib (Ibrance)
  • Ribociclib (Kisqali)
  • Abemaciclib (Verzenio)

Used for: HR-positive, HER2-negative breast cancer that has spread (metastatic)

3. PI3K/AKT/mTOR pathway inhibitors

Some cancers depend on a signal chain called the PI3K/AKT/mTOR pathway to survive. Blocking it can help stop the tumour from growing.

Examples:

  • Alpelisib (Piqray): for tumours with a PIK3CA gene change.
  • Everolimus (Afinitor): often given with hormone therapy.

Used for: HR-positive, HER2-negative breast cancers with certain gene changes

4. PARP inhibitors

If you have a BRCA1 or BRCA2 gene change, PARP inhibitors may help you. These medicines stop cancer cells from fixing their DNA, so the cells die.

Examples:

  • Olaparib (Lynparza)
  • Talazoparib (Talzenna)

Used for: BRCA-changed, HER2-negative breast cancers that have spread

5. Antibody-drug conjugates (ADCs)

ADCs are a new and exciting step. They join targeted therapy with chemotherapy. The antibody finds the cancer cell, and the chemo attached to it kills the cell.

Examples:

  • Trastuzumab deruxtecan (Enhertu) - used in HER2-low or HER2-positive cancers.
  • Sacituzumab govitecan (Trodelvy) - works for triple-negative breast cancer (TNBC).

Used for: HER2-positive, HER2-low or TNBC

Latest advances in targeted therapy for breast cancer

Research in breast cancer is moving fast. Here are some hopeful new steps:

1. Targeted therapy for HER2-low cancer

Earlier, only HER2-positive cancers responded to HER2 medicines. Now research shows that even low levels of HER2 can be targeted. This opens treatment for more patients.

  • Enhertu has shown very good results in HER2-low breast cancers.
  • Because of this, many more women can now benefit from targeted therapy.

2. Combining treatments

Researchers are testing targeted therapy together with:

  • Immunotherapy: helps your own immune system fight the cancer.
  • Hormone therapy: blocks estrogen or progesterone signals.
  • Chemotherapy: attacks cancer cells in more than one way.

Using treatments together often gives better response and longer life.

3. Liquid biopsy to check progress

New tests like the liquid biopsy let us see how the tumour is responding with just a simple blood test. So we can change treatment faster and more correctly.

4. Gene testing of the tumour

Next-generation sequencing (NGS) is a test that shows the gene changes driving the tumour. Then I can plan treatment for your own cancer. It works better and avoids side effects you don't need.

Benefits of targeted therapy for breast cancer

Targeted therapy has many benefits over older treatments:

  • More exact: it aims straight at cancer cells.
  • Fewer side effects: healthy cells are often left alone.
  • Planned for you: treatment is based on how your tumour behaves.
  • Better results: it often helps people live longer, and keeps the cancer from growing for longer.
  • Can be combined: it can be used with other treatments for a stronger effect.

Possible side effects you should know

Targeted therapy is usually easier than chemo. But side effects can still happen. They depend on the medicine and on your body:

  • Tiredness
  • Nausea or loose motions (diarrhoea)
  • Changes in liver tests
  • Heart problems (rare, mostly with HER2 medicines)
  • Skin or nail changes

Regular check-ups help me catch and manage these early.

How doctors decide on targeted therapy

Before starting targeted therapy, your oncologist will usually ask for biomarker tests: tests that check the genes and proteins of your tumour. Based on the results, your plan may include:

  • One targeted medicine
  • Two or more targeted medicines together
  • Targeted therapy with other treatments (like hormone therapy or immunotherapy)

The choice depends on:

  • The stage and type of cancer
  • Certain gene changes (HER2, BRCA, PIK3CA, etc.)
  • Past treatments and your general health

FAQs about targeted therapy for breast cancer

  1. Is targeted therapy a cure for breast cancer?
    Usually not by itself. But it can slow down or stop cancer growth a lot, help you live longer and feel better.
  2. How long does targeted therapy last?
    It depends on your plan. Some patients take it for a few months. Others continue it for years to keep the cancer under control.
  3. Can targeted therapy replace chemotherapy?
    Sometimes, yes. But more often I use it together with chemo, hormone therapy or immunotherapy for stronger results.
  4. Is targeted therapy safe?
    Yes, usually. Most people handle it well, but side effects can still happen. Please talk about the risks with your oncologist.

How do I know if I'm eligible?

A simple molecular or gene test of your tumour tells us if targeted therapy is a good option for you.

Conclusion

Targeted therapy for breast cancer has changed how we treat this disease. Instead of one plan for everyone, we can now make a plan based on how your own cancer behaves. It has fewer side effects, gives better results, and now helps some types of cancer that were hard to treat before. That is why targeted therapy is the future of cancer care.

If you or someone in your family has breast cancer, please ask your oncologist about gene testing of the tumour, and whether targeted therapy can be part of your plan. Breast cancer care today is more exact and more personal than ever.

Treatment information: Breast Cancer Treatment in Ahmedabad: Signs, Tests, Stages and Care

Related patient guides

This page is for general information and does not replace a consultation. Treatment decisions depend on each patient's diagnosis.

CallWhatsApp